187 related articles for article (PubMed ID: 36727039)
1.
Yang J; Dong X; Li B; Chen T; Yu B; Wang X; Dou X; Peng B; Hu Q
Front Bioeng Biotechnol; 2022; 10():1050077. PubMed ID: 36727039
[No Abstract] [Full Text] [Related]
2. Poria cocos polysaccharide induced Th1-type immune responses to ovalbumin in mice.
Dong X; Li B; Yu B; Chen T; Hu Q; Peng B; Sheng W
PLoS One; 2021; 16(1):e0245207. PubMed ID: 33411807
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization and adjuvant activity of a water soluble polysaccharide from Poria cocos.
Gu P; Xu P; Zhu Y; Zhao Q; Zhao X; Fan Y; Wang X; Ma N; Bao Y; Shi W
Int J Biol Macromol; 2024 Jun; 273(Pt 1):133067. PubMed ID: 38866287
[TBL] [Abstract][Full Text] [Related]
4. Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines.
Li N; Zhang Y; Han M; Liu T; Wu J; Xiong Y; Fan Y; Ye F; Jin B; Zhang Y; Sun G; Sun X; Dong Z
Sci China Life Sci; 2024 Apr; 67(4):680-697. PubMed ID: 38206438
[TBL] [Abstract][Full Text] [Related]
5. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
[TBL] [Abstract][Full Text] [Related]
6. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination.
Wang X; Cao F; Yan M; Liu Y; Zhu X; Sun H; Ma G
Acta Biomater; 2019 Jan; 83():390-399. PubMed ID: 30448435
[TBL] [Abstract][Full Text] [Related]
7. Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses.
Wang N; Zuo Y; Wu S; Huang C; Zhang L; Zhu D
Acta Pharm Sin B; 2022 Dec; 12(12):4486-4500. PubMed ID: 36561992
[TBL] [Abstract][Full Text] [Related]
8. Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy.
Xu J; Wang H; Xu L; Chao Y; Wang C; Han X; Dong Z; Chang H; Peng R; Cheng Y; Liu Z
Biomaterials; 2019 Jul; 207():1-9. PubMed ID: 30947117
[TBL] [Abstract][Full Text] [Related]
9. Polysaccharide PCP-I isolated from
Liu K; Yin Y; Zhang J; Zai X; Li R; Ma H; Xu J; Shan J; Chen W
Hum Vaccin Immunother; 2020 Jul; 16(7):1699-1707. PubMed ID: 31809637
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of PCP-II, a polysaccharide from Poria cocos, on a whole killed rabies vaccine.
Zhang W; Cheng N; Wang Y; Zheng X; Zhao Y; Wang H; Wang C; Han Q; Gao Y; Shan J; Yang S; Xia X
Virus Res; 2019 Sep; 270():197638. PubMed ID: 31173772
[TBL] [Abstract][Full Text] [Related]
11. Nanoscale Coordination Polymer Based Nanovaccine for Tumor Immunotherapy.
Zhao H; Xu J; Li Y; Guan X; Han X; Xu Y; Zhou H; Peng R; Wang J; Liu Z
ACS Nano; 2019 Nov; 13(11):13127-13135. PubMed ID: 31710460
[TBL] [Abstract][Full Text] [Related]
12. In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.
Villegas-Mendez A; Garin MI; Pineda-Molina E; Veratti E; Bueren JA; Fender P; Lenormand JL
Mol Ther; 2010 May; 18(5):1046-53. PubMed ID: 20179681
[TBL] [Abstract][Full Text] [Related]
13. Effect of a polysaccharide from Poria cocos on humoral response in mice immunized by H1N1 influenza and HBsAg vaccines.
Wu Y; Li S; Li H; Zhao C; Ma H; Zhao X; Wu J; Liu K; Shan J; Wang Y
Int J Biol Macromol; 2016 Oct; 91():248-57. PubMed ID: 27185068
[TBL] [Abstract][Full Text] [Related]
14. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase.
Guan X; Chen J; Hu Y; Lin L; Sun P; Tian H; Chen X
Biomaterials; 2018 Jul; 171():198-206. PubMed ID: 29698869
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination.
Chou PY; Lin SY; Wu YN; Shen CY; Sheu MT; Ho HO
J Control Release; 2022 Nov; 351():970-988. PubMed ID: 36220488
[TBL] [Abstract][Full Text] [Related]
16. Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy.
Liang Z; Cui X; Yang L; Hu Q; Li D; Zhang X; Han L; Shi S; Shen Y; Zhao W; Ju Q; Deng X; Wu Y; Sheng W
Int J Pharm; 2021 Oct; 608():121091. PubMed ID: 34555477
[TBL] [Abstract][Full Text] [Related]
17. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
18. Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy.
Gao ZL; Xu W; Zheng SJ; Duan QJ; Liu R; Du JZ
Nano Lett; 2023 Mar; 23(5):1904-1913. PubMed ID: 36801829
[TBL] [Abstract][Full Text] [Related]
19. Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy.
Dong Y; Gao J; Pei M; Wang X; Zhang C; Du Y; Jiang Y
Int J Nanomedicine; 2020; 15():2685-2697. PubMed ID: 32368049
[TBL] [Abstract][Full Text] [Related]
20. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
